Unified Medical Language System (UMLS). Medical Subject Headings (MeSH)

MeSH 2025
Enter one or more words or parts of words

Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-((3,4,5-trimethoxybenzoyl)oxy)-, methyl ester, (3beta,16beta,17alpha,18beta,20alpha)-, mixt. with 4-chloro-N(1)-methyl-N(1)-((tetrahydro-2-methyl-2-furanyl)methyl)-1,3-benzenedisulfonamide and myo-inositol hexa-3-pyridinecarboxylate (MeSH)
Search & browse in old database

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-((3,4,5-trimethoxybenzoyl)oxy)-, methyl ester, (3beta,16beta,17alpha,18beta,20alpha)-, mixt. with 4-chloro-N(1)-methyl-N(1)-((tetrahydro-2-methyl-2-furanyl)methyl)-1,3-benzenedisulfonamide and myo-inositol hexa-3-pyridinecarboxylate (MeSH) - C0053099
L0158901
S0217024
A0239274
M0040313
MeSH N1 C000242 doctor.am